Table 2.
SHR (95% Cl) | P- value | |
---|---|---|
Agea | 1.13 (1.11–1.15) | P<0.001 |
Method of H pylori diagnosis | ||
Positive diagnostic test | REFERENCE | 0.006 |
RX, no serum Ab | 0.95(0.82–1.10) | |
ICD, no serum Ab | 0.89(0.65–1.23) | |
RX, with serum Ab | 0.83(0.59–1.17) | |
ICD, with serum Ab | 0.75 (0.62–0.90) | |
Ethnicity | ||
Not Hispanic or Latino | REFERENCE | |
Hispanic or Latino | 1.59(1.34–1.87) | P<0.001 |
Unknown | 1.30 (1.08–1.55) | |
Race | ||
White | REFERENCE | |
Black or African American | 2.00 (1.80–2.22) | P<0.001 |
American Indian or Alaskan Native | 1.36(0.84–2.19) | |
Asian | 2.52(1.64–3.89) | |
Native Hawaiian or other Pacific Islander | 0.82(0.48–1.42) | |
Unknown | 1.08(0.91–1.29) | |
History of smoking | 1.38(1.25–1.52) | P<0.001 |
Female gender | 0.52 (0.40–0.68) | P<0.001 |
Poverty level of zip code where patient resided at H pylori diagnosis | ||
< 10% residing below poverty level | REFERENCE | |
10 − 24.9% residing below poverty level | 0.86 (0.77–0.97) | 0.09 |
25 − 49.9% residing below poverty level | 0.95(0.84–1.09) | |
≥50% residing below poverty level | 0.99(0.76–1.29) | |
Unknown | 0.83(0.65–1.06) |
Age is per 5-year incremental increase in year
RX = prescription therapy; ICD = International Classification of Diseases (administrative codes); Ab = antibody